Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation

Thrombotic microangiopathy is a form of antibody-mediated rejection (ABMR): it is the main complication of ABO-incompatible (ABOi) kidney transplantation (KT). Herein, we report on two cases of ABMR with biological and histological features of thrombotic microangiopathy (TMA) that were treated by ec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Transplant
Glavni autori: Lanfranco, Luca, Joly, Melanie, Del Bello, Arnaud, Esposito, Laure, Cognard, Noelle, Perrin, Peggy, Moulin, Bruno, Kamar, Nassim, Caillard, Sophie
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763091/
https://ncbi.nlm.nih.gov/pubmed/29445563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3197042
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items